Sernova Corp. (TSE:SVA – Get Free Report) reached a new 52-week low during trading on Tuesday . The company traded as low as C$0.18 and last traded at C$0.19, with a volume of 1500 shares. The stock had previously closed at C$0.18.
Sernova Price Performance
The firm has a fifty day moving average price of C$0.20 and a two-hundred day moving average price of C$0.23. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40. The stock has a market capitalization of C$62.25 million, a P/E ratio of -1.79 and a beta of 1.35.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Read More
- Five stocks we like better than Sernova
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Use the MarketBeat Excel Dividend Calculator
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
